ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Methanol → 4-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

HRID 279336
印刷

反応式

HRID 279336 の反応式
C(OC([NH:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1)=[O:16])=[O:12])=O)(C)(C)C.BrC[C:33]1[CH:41]=[CH:40][C:36]2=[N:37][O:38][N:39]=[C:35]2[CH:34]=1.C1CCNCC1.CO>C(Cl)(Cl)Cl.C(#N)C>[NH2:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:20][CH2:21][N:22]([C:33]2[CH:41]=[CH:40][C:36]3=[N:37][O:38][N:39]=[C:35]3[CH:34]=2)[CH2:23][CH2:24]1)=[O:16])=[O:12]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 887MethanolHCID 8082PiperidineHCID 27355875-(Bromomethyl)-2,1,3-benzoxadiazoleHCID 184262024-[[N-(2-(tert-butoxycarbonylamino)-4,5-difluorobenzoyl)glycyl]aminomethyl]piperidine

生成物 1

HCID 184262184-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

試薬・触媒・溶媒 2

HCID 6212
Chloroform
溶媒
HCID 6342Acetonitrile溶媒

反応条件

温度
50 °C

実験手順

A mixture of 4-[{N-(2-(tert-butoxycarbonylamino)-4, 5-difluorobenzoyl)glycyl}aminomethyl]piperidine (0.050 mmol), 5-(bromomethyl)benzo[c]furazan (0.75 mmol), (piperidinomethyl)polystyrene (2.6-2.8 mmol/g, 60 mg, 0.15 mmol), methanol (0.2 mL), acetonitrile (1.0 mL), and chloroform (0.50 mL) was stirred at 50° C. overnight. The mixture was cooled to room temperature, loaded onto Varian™ SCX column, and washed with CH3OH (5 mL×2). Product was eluted off using 2 N NH3 in CH3OH (5 mL) and concentrated. To the resulting material were added chloroform (1.5 mL) and phenyl isocyanate (0.075 mL) and the solution was stirred at room temperature for 1 h, loaded onto Varian™ SCX column, and washed with CH3OH (5 mL×2). Product was eluted off using 2 N NH3 in CH3OH (5 mL) and concentrated. The residue was dissolved in methanol (1 mL) and 4 N HCl in dioxane (0.50 mL) was added. The solution was stirred at room temperature overnight and concentrated. The residue was dissolved in methanol, loaded onto Varian™ SCX column, washed with CH3OH (5 mL×2), and eluted off using 2 N NH3 in CH3OH (5 mL). Concentration and preparative TLC (SiO2, ethyl acetate/MeOH=5/1) afforded 4-[{N-(2-amino-4,5-difluorobenzoyl)glycyl}aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine (Compound No. 2130) (3.6 mg, 16%): The purity was determined by RPLC/MS (87%); ESI/MS m/e 459.3 (M++H, C22H24F2N6O3).

後処理

  1. temperatureThe mixture was cooled to room temperature
  2. washwashed with CH3OH (5 mL×2)
  3. washProduct was eluted off
  4. concentrationconcentrated
  5. additionTo the resulting material were added chloroform (1.5 mL) and phenyl isocyanate (0.075 mL)
  6. stirringthe solution was stirred at room temperature for 1 h
  7. washwashed with CH3OH (5 mL×2)
  8. washProduct was eluted off
  9. concentrationconcentrated
  10. dissolutionThe residue was dissolved in methanol (1 mL)
  11. addition4 N HCl in dioxane (0.50 mL) was added
  12. stirringThe solution was stirred at room temperature overnight
  13. concentrationconcentrated
  14. dissolutionThe residue was dissolved in methanol
  15. washwashed with CH3OH (5 mL×2)
  16. washeluted off
  17. concentrationConcentration and preparative TLC (SiO2, ethyl acetate/MeOH=5/1)

出典と根拠

ORDレコード
ord-472e39f9e7e44251bdb3e58ffb5c4e8b
出典データセット
uspto-grants-2002_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06362177B1

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート